Spain’s new three-pronged strategic plan to bolster the pharmaceutical industry will also strengthen research and innovation, improve timely access to medicines and ensure strategic autonomy in the production of medicines.
The plan will mean an overhaul of the current pricing and reimbursement system, including the creation of a new system for evaluating the efficiency of new. Improving the R&D infrastructure,...